Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis

References

• Bufano G, Usberti M, Mandolfo S, Malberti F, Piroddi M, Galli F. Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers. Int J Artif Organs. 2004;27(3):214–221
   PubMedGoogle Scholar
• Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem. 2011;44(14–15):1189–1198
   PubMedGoogle Scholar
• Huang KC, Yang CC, Hsu SP, et al. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients. Kidney Int. 2006;70(2):391–398
   PubMedGoogle Scholar
• Lemoine S, Fournier T, Kocevar G, et al. Dialysis. Protein-energy wasting, inflammation and oxidative stress. Nephrol Dial Transplant. 2014;29(Suppl 3):iii287–iii303
   Google Scholar
• Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis. Ann Nutr Metab. 2009;55(4):309–316
   PubMedGoogle Scholar
• Panichi V, Scatena A, Migliori M, Marchetti V, Paoletti S, Beati S. Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. Int J Inflam. 2012;2012:360147
   PubMedGoogle Scholar
• Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286–294
   PubMed Web of Science ®Google Scholar
• Panichi V, Rosati A, Paoletti S, et al. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: Results of a randomized cross-over multicenter trial. Blood Purif. 2011;32(1):7–14
   PubMedGoogle Scholar
• Marques de Mattos A, Marino LV, Ovidio PP, Jordao AA, Almeida CC, Chiarello PG. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16(1):68–74
   PubMed Web of Science ®Google Scholar
• Wratten ML, Galaris D, Tetta C, Sevanian A. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signal. 2002;4(6):935–944
   PubMedGoogle Scholar
• Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21(10):2825–2833
   PubMedGoogle Scholar
• Yang SK, Xiao L, Xu B, Xu XX, Liu FY, Sun L. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: A systematic review and meta-analysis. Ren Fail. 2014;36(5):722–731
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int. 2003;63(5):1881–1887
   PubMed Web of Science ®Google Scholar
• Mandolfo S, Corradi B, Bucci R, Farina M, Pilolli F, Galli F. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: A pilot study. Int Urol Nephrol. 2012;44(5):1493–1500
   PubMedGoogle Scholar
• Sanaka T, Mochizuki T, Kinugasa E, et al. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response. Clin J Am Soc Nephrol. 2013;8(6):969–978
   PubMedGoogle Scholar
• Lines SW, Carter AM, Dunn EJ, Lindley EJ, Tattersall JE, Wright MJ. A randomized controlled trial evaluating the erythropoiesis stimulating agent sparing potential of a vitamin E-bonded polysulfone dialysis membrane. Nephrol Dial Transplant. 2014;29(3):649–656
   PubMedGoogle Scholar
• Higgins JP. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; March 2011. Available at: http://www.cochrane-handbook.org
   Google Scholar
• Review Manager (RevMan) [Computer program]. The Nordic Cochrane Centre. Version 5.3. Copenhagen: The Cochrane Collaboration; June 2014. Available from: http://tech.cochrane.org/revman/
   Google Scholar
• Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193–206
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634
   PubMed Web of Science ®Google Scholar
• Baragetti I, Furiani S, Vettoretti S, et al. Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study. Blood Purif. 2006;24(4):369–376
   PubMedGoogle Scholar
• Andrulli S, Di Filippo S, Manzoni C, et al. Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study. Nephron Clin Pract. 2010;115(1):c82–c89
   PubMedGoogle Scholar
• Clermont G, Lecour S, Cabanne JF, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31(2):233–241
   PubMedGoogle Scholar
• Kirmizis D, Papagianni A, Belechri AM, Memmos D. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic hemodialysis. Nephrol Dial Transplant. 2011;26(7):2296–2301
   PubMedGoogle Scholar
• Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant. 2005;20(12):2775–2782
   PubMedGoogle Scholar
• Nakamura T, Kawagoe Y, Matsuda T, et al. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res. 2003;26(3):185–191
   PubMedGoogle Scholar
• Usberti M, Gerardi G, Bufano G, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis. 2002;40(3):590–599
   PubMed Web of Science ®Google Scholar
• Al-Jondeby MS, Cabaguing IT, Pajarillo AA, et al. Comparative crossover controlled study using polysulphone and vitamin E coated dialyzers. Saudi Med J. 2003;24(3):265–268
   PubMedGoogle Scholar
• Eiselt J, Racek J, Trefil L, Opatrny K Jr. Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif Organs. 2001;25(6):430–436
   PubMedGoogle Scholar
• Akiyama S, Inagaki M, Tsuji M, et al. Comparison of effect of vitamin E-coated dialyzer and oral vitamin E on hemodialysis-induced Cu/Zn-superoxide dismutase. Am J Nephrol. 2005;25(5):500–506
   PubMedGoogle Scholar
• Sasaki M, Hosoya N, Saruhashi M. Development of vitamin E-modified membrane. Contrib Nephrol. 1999;127:49–70
   PubMedGoogle Scholar
• Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs. 2006;9(1):50–60
   PubMedGoogle Scholar
• Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in hemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12(11):2312–2317
   PubMedGoogle Scholar
• Antoniadi G, Eleftheriadis T, Liakopoulos V, et al. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial. 2008;12(3):237–242
   PubMedGoogle Scholar
• Rao P, Reddy GC, Kanagasabapathy AS. Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease. Indian J Clin Biochem. 2008;23(3):209–217
   PubMedGoogle Scholar
• de Mutsert R, Krediet RT. Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients. Ned Tijdschr Geneeskd. 2006;150(37):2023–2027
   PubMedGoogle Scholar
• Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):461–467
   PubMed Web of Science ®Google Scholar
• Kim Y, Molnar MZ, Rattanasompattikul M, et al. Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol. 2013;45(1):215–227
   PubMed Web of Science ®Google Scholar
• Streja E, Kovesdy CP, Molnar MZ, et al. Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis. 2011;57(6):883–893
   PubMedGoogle Scholar
• Rambod M, Bross R, Zitterkoph J, et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: A 5-year prospective cohort study. Am J Kidney Dis. 2009;53(2):298–309
   PubMed Web of Science ®Google Scholar
• Drueke TB, Massy ZA. Atherosclerosis in CKD: Differences from the general population. Nat Rev Nephrol. 2010;6(12):723–735
   PubMedGoogle Scholar
• Olyaei A, Greer E, Delos Santos R, Rueda J. The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients. Clin J Am Soc Nephrol. 2011;6(3):664–678
   PubMed Web of Science ®Google Scholar